logo text with star

Comparative Effectiveness Research on Cancer in Texas (CERCIT) is a statewide resource for outcomes and comparative effectiveness research funded by The Cancer Prevention Research Institute of Texas (CPRIT), RP160674

About UsComparative Effectiveness Research on Cancer in Texas (CERCIT)

The first five years of CERCIT (2010-2015) aimed to increase the evidence to support individualized care by assessing outcomes of treatment in comparative effectiveness research (CER) using large administrative databases. The program was renewed in 2016 through 2020 to build on our analyses and expand our methods to better measure individual patient characteristics, focusing on patient preferences and patient reported outcomes.

Our goal is to generate evidence that will assist patients and their physicians in individualized decision making when faced with choices among different options in screening, treatment, and survivorship care in cancer.

Current Projects include Project 1: Cancer screening in Texas, Project 2: Providing Evidence for Individualized Decision Making About Chemotherapy in Older Patients, Project 3: Assisting Cancer Patients with Surgery and Radiation Treatment Choices, and Project 4: Investigating Patient Preferences Regarding End-of-Life Care Among Cancer Patients in Texas.

Projects are supported by three Cores: the Administrative Core, the Data Analysis Management Core and the Survery Core.

Cores and projects support the overall goal of providing information to promote individualized cancer care

UTMB_header_logo_small
MDAlogo
uthealth-logo
University_of_Texas_SW_Medical_Center_Logo
TCR_DSHS_logo
cprit

CERCIT is a multidisciplinary consortium of investigators at the University of Texas Medical Branch (UTMB), MD Anderson Cancer Center (MDACC), UT Health Science Center at Houston (UTHealth), UT Southwestern Medical Center in Dallas (UTSW), and the Texas Department of State Health Services Texas Cancer Registry. CERCIT is funded by the Cancer Prevention Research Institute of Texas (CPRIT). Manuscript Acknowledgement: This work was supported [in part] by the Comparative Effectiveness Research on Cancer in Texas (CERCIT) Grant #RP160674, funded by The Cancer Prevention Research Institute of Texas (CPRIT).